TY - JOUR
T1 - Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro
AU - Richelson, Elliott
AU - Nelson, Albert
N1 - Funding Information:
compounds. This work was supported by a grant from Dupont Pharmaceuticals and by the Mayo Foundation.
PY - 1984/8/17
Y1 - 1984/8/17
N2 - Using radioligand binding techniques, we determined the equilibrium dissociation constants (KD's) for a series of neuroleptics at the dopamine (D-2), muscarinic, histamine H1, α1- and α2-adrenergic receptors of normal human brain tissue obtained at autopsy. Seventeen different compounds were studied at the D-2 receptor and 15 compounds at the remaining receptors. At the D-2 receptor of caudate nucleus, spiperone was the most potent compound (KD = 0.16 nM); clozapine the least potent (KD = 180 nM). The KD's for six compounds at the D-2 receptor of nucleus accumbens were not significantly different from their respective KD's in the caudate nucleus. The most potent and least potent compounds at the other receptors were clozapine and molindone at the muscarinic receptor, mesoridazine and molindone at the H1 receptor, spiperone and molindone at the α1-receptor, and clozapine and haloperidol at the α2-receptor, respectively.
AB - Using radioligand binding techniques, we determined the equilibrium dissociation constants (KD's) for a series of neuroleptics at the dopamine (D-2), muscarinic, histamine H1, α1- and α2-adrenergic receptors of normal human brain tissue obtained at autopsy. Seventeen different compounds were studied at the D-2 receptor and 15 compounds at the remaining receptors. At the D-2 receptor of caudate nucleus, spiperone was the most potent compound (KD = 0.16 nM); clozapine the least potent (KD = 180 nM). The KD's for six compounds at the D-2 receptor of nucleus accumbens were not significantly different from their respective KD's in the caudate nucleus. The most potent and least potent compounds at the other receptors were clozapine and molindone at the muscarinic receptor, mesoridazine and molindone at the H1 receptor, spiperone and molindone at the α1-receptor, and clozapine and haloperidol at the α2-receptor, respectively.
KW - Antipsychotics
KW - Dopamine (D-2) receptor
KW - Histamine H receptor
KW - Muscarinic receptor
KW - α-Adrenergic receptors
UR - http://www.scopus.com/inward/record.url?scp=0021177284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021177284&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(84)90478-3
DO - 10.1016/0014-2999(84)90478-3
M3 - Article
C2 - 6149136
AN - SCOPUS:0021177284
SN - 0014-2999
VL - 103
SP - 197
EP - 204
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3-4
ER -